New series: action mechanisms of drugs
Fredholm, B.B.
Lakartidningen 94(19): 1787-1788
1997
ISSN/ISBN: 0023-7205 PMID: 9190457 Document Number: 483701
Document emailed within 1 workday
Related Documents
Bignell, C.M.; Dunlop, P.J.; Brophy, J.J.; Jackson, J.F. 1996: Volatile leaf oils of some south-western and southern Australian species of genus Eucalyptus (Series I). Part XIII. (Series I). (a) Series Subulatae, (b) Series Curviptera, (c) Series Contortae, (d) Series Incognitae, (e) Series Terminaliptera, (f) Series Inclusae, (g) Series Microcorythae and (h) Series Cornutae Flavour and Fragrance Journal 11(6): 339-347Nagayama, D.; Shirai, K. 2009: Action mechanisms of anti-obesity drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 67(2): 385-391
Takashina, J. 1956: Studies on action mechanisms of antituberculous drugs. I. Studies on inhibitory action of SM, PAS, INH against BCG dehydrogenase Science Reports of the Research Institutes, Tohoku University, Series C: Medicine 7(2): 187-194
Harth, M. 1992: Mechanisms of action of disease modifying antirheumatic drugs Journal of Rheumatology. Suppl 32: 100-103
Timmerman, H. 1984: Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate British Journal of Clinical Practice. Suppl 34: 10-19
Lipsky, P.E. 1989: Mechanisms of action of slow-acting drugs in rheumatoid arthritis Clinical and Experimental Rheumatology 7(Suppl 3): S177-S180
Longo, V.G.; Scotti de Carolis, A. 1978: EEG methods in the study of the mechanisms and site of action of centrally acting drugs Annali Dell'istituto Superiore di Sanita 14(1): 27-34
Schäfer-Korting, M. 2003: New systemic antifungal drugs: mechanisms of action, drug interactions and side effects Mycoses 46(Suppl): 28-31
Youle, R J. 2003: Haya Lorberboum-Galski and Philip Lazarovici (Eds.). Chimeric Toxins: Mechanisms of Action and Therapeutic Applications (Cell and Molecular Mechanisms of Toxin Action) International Journal of Toxicology 22(4): 331-332
Coquoz, D.; Porchet, H.C.; Dayer, P. 1991: Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide Schweizerische Medizinische Wochenschrift 121(49): 1843-1845
Mathies, H. 1989: Immunopathologic and inflammatory processes in chronic polyarthritis. Discussion principles of the mechanisms of action of antirheumatic drugs Fortschritte der Medizin 107(9): 197-200
Benesová, O. 1994: Nootropic drugs and their action mechanisms in relation to the neuropathobiology of senile dementia. I. Neurotransmission disorders in the brain Ceskoslovenska Psychiatrie 90(4): 191-200
Van Den Driessche, J.; Lacroix, P.; Linee, P.; Le Polles, J.B.; Pape, D.; Allain, H. 1979: Activity of some drugs on the electroencephalogram of curarized rats during acute and iterative hypercapnic anoxia Hypotheses on mechanisms of action Archives Internationales de Pharmacodynamie et de Therapie 239(1): 62-77
Cocchi, R.; Fusari, A.; Lorini, G.; Roccia, L. 1977: Acupunctura, "vital" drugs and psychopharmacological agents in the treatment of psychiatric patients with deep depressive disorders, with considerations on the probable neurophysiological mechanisms of the synergism of action Minerva Medica 68(33): 2309-2314
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Bartolo, M.; Di Folca, A.; Ricci, S. 1981: Plethysmographic researches on the beginning and duration of the pharmacological action of an isosorbide dinitrate drugs with prolonged action Giornale Italiano di Cardiologia 11(9): 1283-1287
Abdel-Rehim, S.; Bagirathan, S.; Al-Benna, S.; O'Boyle, C. 2014: Burns from ECG leads in an MRI scanner: Case series and discussion of mechanisms Annals of Burns and Fire Disasters 27(4): 215-218
Kozhanova, S.V.; Fedorova, K.N.; Spitkovskiĭ, D.M. 1971: Some aspects of the modification of lymphoid cell chromatin under the action of mitogens and mechanisms of action of mitogens Biulleten' Eksperimental'noi Biologii i Meditsiny 72(10): 104-107
Vinogradov, V.M.; Spivakova, R.P. 1973: The mechanism of action of sympatholytics of the guanethidine series Farmakologiia i Toksikologiia 36(3): 273-276
Orel, R.; Murch, S.; Amil Dias, J.; Vandenplas, Y.; Homan, M. 2016: Eosinophilic esophagitis that develops during therapy with proton pump inhibitors : case series and possible mechanisms Acta Gastro-Enterologica Belgica 79(2): 245-250